Saratoga Ventures

Clinical Maestro™ by Strategikon Pharma is the only commercially available software platform for the end- to- end management of “clinical business operations”, which is the pharmaceutical industry vertical for planning, outsourcing and budgeting clinical trials. Biopharmaceutical companies outsource 90% of their clinical development pipeline spending billions of dollars engaging in highly complex outsourced relationships with thousands of global service providers, each using their own processes, systems and reporting structures. These sophisticated relationships require complex outsourcing strategies, demanding clinical financial planning, extensive sourcing due diligence and rigorous performance management. Currently the industry manages these activities in Excel, using labor intensive, inefficient processes, costing billions of dollars in infrastructure costs, regulatory non-compliance fines and delays to market. Clinical Maestro takes a radically different approach to the management of clinical portfolio through a transformative redesign of Excel-driven processes into end-to-end integrated workflows, breaking the communication and data integration siloes between pharma companies and their outsourcing partners. Clinical Maestro™ cases studies with leading pharmaceutical companies and CROs demonstrate savings of >80% vs. manual processes, >95% prediction accuracy for clinical study budgets and high user satisfaction and engagement.

MyoScience Inc. engages in development and commercialization of technology driven dermatological products. MyoScience Inc. was founded in 2005 and is headquartered in Redwood City, California.

MyoScience Inc. engages in development and commercialization of technology driven dermatological products. MyoScience Inc. was founded in 2005 and is headquartered in Redwood City, California.

FRP Products is provides surface preparation and engineering related services to petrochemical companies. The company’s services include fibreglass lamination and repair, protective coating applications, tank-lining applications, thermal spray coating (TSA), factory blasting and painting, dust-free abrasive blast cleaning, and scaffolding and insulation works. It serves in oil, petrochemical, and pharmaceutical industries.

Tibion Corporation, a medical device company, engages in the design and development of bionic devices for the mobility impaired. Its bionic technologies provide non-invasive actively-assisted mobility enhancement and rehabilitation for impaired by surgical recovery, stroke, aging, or loss of muscle function. The company provides PowerKnee, a wearable bionic device for the leg to enhance rehabilitation and help patients improve muscle strength and function, as well as to provide assistance with activities of daily living. Its products are enabled by innovations in orthotics, biomechanics, and embedded control systems. The company was founded in 2002 and is based in Moffett Field, California.

Hotspur Technologies is a leading developer of catheter-based technologies aimed at restoring blood flow for patients with obstructed vessels. The company's products are based on unique and groundbreaking technology that opens blood vessels more efficiently and less invasively.

MyoScience Inc. engages in development and commercialization of technology driven dermatological products. MyoScience Inc. was founded in 2005 and is headquartered in Redwood City, California.

Broncus Technologies is a medical technology company focused on developing minimally-invasive medical devices for emphysema and other lung diseases. Broncus is investigating the Exhale emphysema product line to perform our patented treatment method called Airway Bypass. Airway Bypass could be the first minimally-invasive procedure for the treatment of homogeneous, or diffuse, emphysema, which constitutes the majority of the emphysema patient population. Broncus is currently enrolling patients worldwide in our pivotal EASE Trial investigating a treatment of severe homogeneous emphysema. Broncus is located in Mountain View, CA (San Francisco Bay area). Broncus International is located in Nyon, Switzerland.

Intact Medical Corporation designs, develops, and markets minimally invasive systems for the volumetric excision of tissue for diagnostic and therapeutic applications in select cancer markets. Intact Medical Corporation was formerly known as Neothermia Corporation and changed its name to Intact Medical Corporation in November 2005. It is driven by its mission to alleviate pain, restore health, and extend life. The company was founded in 1998 and is based in Framingham, Massachusetts.